Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > iCeutica Completes GMP Scale-Up for Its Nano-Sized Products

Abstract:
iCeutica, Inc. announces that the first GMP clinical supplies have been manufactured for its partner, Iroko Pharmaceuticals, utilizing iCeutica's proprietary nano-sizing technology. The completion of the manufacturing campaign represents an important technical and commercial validation of the iCeutica platform.

iCeutica Completes GMP Scale-Up for Its Nano-Sized Products

PHILADELPHIA, PA | Posted on June 20th, 2008

"We are very pleased to achieve this significant milestone for iCeutica. Our nano-sizing technology has progressed from pilot plant scale to commercial operation inside a GMP facility and is producing the consistent, quality products that we projected," said iCeutica President and CEO, Matt Callahan.

Iroko and iCeutica are collaborating on the application of iCeutica's nano-sizing platform to reformulate certain proprietary Iroko products. Iroko is guiding the progression of these reformulated products through the regulatory process, clinical trials and ultimate commercial launch.

"The products Iroko is developing with iCeutica will have significant and relevant benefits for patients, with enhanced onset of action, reduction in food-fast effects and potentially reduced side effects," said Iroko President and CEO, John Vavricka.

"iCeutica's nano-sizing platform is broadly applicable to a wide range of poorly soluble drug compounds and provides a novel and exciting approach to formulation development and drug product manufacturing. We look forward to working with our partners and on our internal pipeline in maximizing the potential of this important new technology," said Mr. Callahan.

####

About iCeutica, Inc.
iCeutica commercializes products developed utilizing its proprietary nano-sizing platform. The technology is an enabling reformulation platform, which provides simple and scalable processes to reformulate development stage and marketed products with solubility, delivery or bioavailability challenges.

About Iroko Pharmaceuticals LLC: Iroko is a pharmaceutical company focused on specialty therapeutic areas. The company acquires, develops and maximizes the potential of currently marketed pharmaceutical products. Iroko increases the revenues of acquired products through focused selling and marketing efforts and product life cycle management activities including development of relevant formulations to improve patient treatment.

For more information, please click here

Contacts:
iCeutica, Inc.
Lisa Gray, EVP Corporate Development
+1-267-765-3233

Copyright © Business Wire 2008

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Sopping up proteins with thermosponges: Researchers develop novel nanoparticle platform that proves effective in delivering protein-based drugs October 22nd, 2014

Brookhaven Lab Launches Computational Science Initiative:Leveraging computational science expertise and investments across the Laboratory to tackle "big data" challenges October 22nd, 2014

Bipolar Disorder Discovery at the Nano Level: Tiny structures found in brain synapses help scientists better understand disorder October 22nd, 2014

NIST offers electronics industry 2 ways to snoop on self-organizing molecules October 22nd, 2014

Nanomedicine

Sopping up proteins with thermosponges: Researchers develop novel nanoparticle platform that proves effective in delivering protein-based drugs October 22nd, 2014

Bipolar Disorder Discovery at the Nano Level: Tiny structures found in brain synapses help scientists better understand disorder October 22nd, 2014

Journal Nanotechnology Progress International (JONPI), 2014, Volume 5, Issue 1, pp 1-24 October 22nd, 2014

TARA Biosystems and Harris & Harris Group Form Company to Improve Safety and Efficacy of New Therapies October 22nd, 2014

Announcements

NanoTechnology for Defense (NT4D) October 22nd, 2014

Mechanism behind nature's sparkles revealed October 22nd, 2014

TARA Biosystems and Harris & Harris Group Form Company to Improve Safety and Efficacy of New Therapies October 22nd, 2014

Researchers patent a nanofluid that improves heat conductivity October 22nd, 2014

Alliances/Partnerships/Distributorships

European Commission opens the gate towards the implementation of Nanomedicine Translation Hub October 16th, 2014

IRLYNX and CEA-Leti to Streamline New CMOS-based Infrared Sensing Modules Dedicated to Human-activities Characterization October 15th, 2014

New VDMA Association "Electronics, Micro and Nano Technologies" founded: Inaugural Meeting in Frankfurt/Main, Germany October 15th, 2014

VDMA photonics steering committee with new members stronger than ever October 14th, 2014

NanoNews-Digest
The latest news from around the world, FREE





  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE